Primary hepatocellular cancer in the explanted liver: Outcome of transplantation and risk factors for HCC recurrence

European Journal of Surgical Oncology

Volumn 33, Issue 7, 2007, Pages 868-873

  Kondili, L A ^a,c   Lala, A ^a   Gunson, B ^a   Hubscher, S ^b   Olliff, S ^b   Elias, E ^a   Bramhall, S ^a   Mutimer, D ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Alpha fetoprotein; Hepatocellular carcinoma; Recurrence; Transplantation

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; EXPLANT; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 34548009824     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.10.001     Document Type: Article

References (30)

1. Parkin M., Bray F., Ferlay J., and Pisani P. Global cancer statistics 2002. CA Cancer J Clin 55 (2005) 74-108
2. Okuda K., Ohtsuki T., Obata H., et al. Natural history or hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56 (1985) 918-928
3. Calvet X., Bruix J., Bru C., et al. Natural history of liver transplantation in Spain. Five year's experience in 249 cases. J Hepatology 10 (1990) 311-317
4. Llovet J.M., Bustamante J., Castells A., et al. Natural history of untreated non-surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29 (1999) 62-67
5. Taylor Robinson S.D., Foster G.R., Arora S., Hargreaves S., and Thomas H.C. Increase in primary liver cancer in the UK, 1979-1994. Lancet 350 (1997) 1142-1143
6. Deuffic S., Poynard T., Buffat L., and Valleron A.J. Trends in primary liver cancer. Lancet 351 (1998) 214-215
7. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
8. Bismuth H., Chiche L., Adam R., Castaing D., Diamond T., and Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218 (1993) 145-151
9. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
10. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33 (2001) 1394-1403
11. Marsh J.W., and Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure?. Liver Transplantation 9 (2003) 693-696
12. Iwatsuki S.h., Dvorchik I., Marsh W., et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 191 (2000) 389-394
13. Edmondson H.A., and Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48 900 necropsies. Cancer 7 (1954) 462-503
14. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. In: Sobin L.H., and Wittekind C.H. (Eds) (1997), Wiley-Liss, New York 74-77
15. American Liver Tumor Study Group. A randomised prospective multiinstitutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigator Booklet and Protocol (1998) United Network for Organ Sharing. Policy 3.6.4.4.1998.
16. United Network for Organ sharing 2002. Available at http/www.unos.org. policy 3.6 (accessed 25.07.2004).
17. Lohe F., Angele M.K., Gerbes A.L., Lohrs U., Jauch K.W., and Schauer R.J. Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol 31 (2005) 994-999
18. Molmenti E.P., and Klintmalm G.B. Liver transplantation in association with hepatocellular carcinoma: an update of the international tumor registry. Liver Transplantation 8 (2002) 736-748
19. Moya A., Berenguer M., Auguilera V., et al. Hepatocellular carcinoma: can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?. Liver Transplantation 8 (2002) 1020-1027
20. Gondolesi G., Munoz L., Matsumoto C., et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg 6 (2002) 102-107
21. Choi B. CT diagnosis of liver cancer. In: Okuda K., and Tabor E. (Eds). Liver cancer (1997), Churchill Livingstone, New York 371-391
22. International Union Against cancer (UICC). TNM classification of malignant tumors. 5th ed. In: Sobin L.H., and Wittekind C.H. (Eds) (1997), Wiley-Liss, New York 74-78
23. Yao F.Y., Ferrell L., Bass N.M., Bacchetti P., Ascher N.L., and Roberts J.P. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburg modified TNM criteria. Liver Transplantation 8 (2002) 765-774
24. Llovet J.M., Bruix J., Fuster J., et al. Liver transplantation for small hepatocellular carcinoma: the Tumor Node Metastasis classification does not have prognostic power. Hepatology 27 (1998) 1572-1577
25. Marsh J.W., Dvorchik I., Bonham C.A., and Iwatsuki S. Is pathologic TNM staging system for patients with hepatoma predictive of outcome?. Cancer 88 (2000) 538-543
26. Figueras J., Ibanez L., Ramos E., et al. Selection criteria for liver transplantation in early -stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transplantation 7 (2001) 877-883
27. Plessier A., Codes L., Consigny Y., et al. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transplantation 10 (2004) S86-S90
28. Rizzi P.M., Kane P.A., Ryder S.D., et al. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology 107 (1994) 1425-1429
29. Gambarin-Gelwan M., Wolf D.C., Shapiro R., Schwartz M.E., and Min A.D. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterology 95 (2000) 1535-1538
30. Libbrecth L., Bielen D., Verslype C., et al. Focal lesion in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transplantation 8 (2002) 749-761